The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1011
October 10, 1997
View Complete Issue         Table of Contents 2019 
Issue 1011
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Bromfenac for Analgesia
October 10, 1997 (Issue: 1011)
Bromfenac sodium (Duract - Wyeth-Ayerst), a nonsteroidal anti-inflammatory drug (NSAID), has been approved by the US Food and Drug Administration (FDA) and is being heavily advertised as an alternative to narcotics for short-term treatment of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1011
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.